|
| |
| | | 38546 | | 03.02.1975 | | Pfizer AG | | 15.12.2004 | | | | | | | | | | | 07.07.23. | | | | 07.07.23. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Depo-Medrol Lidocaine 40 mg/mL | Injektionssuspension | Suspension injectable (Methylprednisolone Acétate 40 mg, Lidocaini Hydrochloridum Monohydricum 10 mg) | H02BX01 | | | 02 | Depo-Medrol Lidocaine 80 mg/2 mL | Injektionssuspension | Suspension injectable (Methylprednisolone Acétate 80 mg, Lidocaini Hydrochloridum Monohydricum 20 mg) | H02BX01 | |
|
|
|
